期刊文献+

成都市新生儿百日咳、白喉、破伤风胎传抗体水平调查 被引量:1

Investigation on Antibody Levels of Pertussis,Diphtheria and Tetanus in Newborns in Chengdu
原文传递
导出
摘要 目的了解成都市新生儿百日咳、白喉、破伤风胎传抗体的水平及其变化情况。方法在4个区县对142名新生儿的脐血进行百日咳、白喉、破伤风抗体水平调查。结果百日咳抗体达到保护水平的率为1.41%,明显低于1988年的抗体水平(χ2=5.80,P<0.05);白喉、破伤风抗毒素平均滴度为0.3750和0.3537,其抗体达到保护水平的率分别为48.59%和52.11%,明显高于1988年的抗体水平(χ2=25.29,P<0.05;χ2=63.49,P<0.05)。结论该市新生儿百日咳、白喉、破伤风胎传抗体水平达不到有效的保护,应重视新生儿父母、与年龄较小儿童接触和其他适合接种白破疫苗的成人的免疫接种,以保护新生儿免受此类疾病的感染。 Objective To understand the antibody levels of pertussis,diphtheria and tetanus in newborns in Chengdu.Methods A total of 142 cord serum samples of newborns from 4 districts and counties were used for antibody level detections of pertussis,diphtheria and tetanus.Results The protection rate of pertussis antibody was 1.41%,which was lower than the level in 1988(χ2=5.80,P0.05).The GMTs of diphtheria and tetanus were 0.375 0 and 0.353 7 with the protection rates of 48.59% and 52.11%,which were higher than the levels in 1988(χ2=25.29,P0.05;χ2=63.49,P0.05).Conclusion The antibody levels of pertussis,diphtheria and tetanus in newborns in Chengdu could not provide effective protection.It is recommended that the parents of newborns,young children and other eligible adults receive DPT vaccination to protect newborns from these diseases.
出处 《预防医学情报杂志》 CAS 2010年第6期479-481,共3页 Journal of Preventive Medicine Information
关键词 新生儿 抗体 百日咳 白喉 破伤风 Newborn Antibody level Pertussis Diphtheria Tetanus
  • 相关文献

参考文献4

二级参考文献4

  • 1王树巧,叶庆帧,谢广钟,徐大麟.上海市区儿童百白破三联制剂免疫血清抗体水平的测定[J]上海医学,1986(03).
  • 2迮文远.计划免疫学[M]上海科学技术文献出版社,1997.
  • 3迮文远.预防接种手册[M]上海科学技术文献出版社,1997.
  • 4卢锦汉等.医学生物制品学[M]人民卫生出版社,1995.

共引文献8

同被引文献35

  • 1赵铠.扩大免疫规划范围 促进疫苗产业发展[J].中国医药生物技术,2007,2(3). 被引量:12
  • 2孟成艳,张文宏.全球百日咳疾病负担的现状与展望[J].中国计划免疫,2006,12(4):318-321. 被引量:24
  • 3卫生部.扩大国家免疫规划实旋方案[s].2007-12-30.
  • 4Halperin SA, King J, Law B, et al. P. Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine for the first four doses [J]. Clin Infect Dis, 1999, 28 (5) :995-1001.
  • 5Mills E, Gold R, Thipphawong J, et al. Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus- inactivated poliomyelitis-Haemophilus b conjugate vaccine administered to infants at two, four and six months of age[J]. Vaccine, 1998, 16 (6) :576-585.
  • 6Meriste S, Lutsar I, Tamm E, et al. Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated pohovirus vaccine [J ]. Scand J Infect Dis, 2006, 38 (5):350-356.
  • 7FDA. Guidance for Industry for the Evaluation of Combination Vaccines for Preventive Diseases: Product, Testing and Clinical Studies[S]. April 1997.
  • 8WHO. WHO Vaccine Preventive Diseases Monitoring System[S]. Immunization schedules by antigen, selection centre, Geneva, 2007.
  • 9Li RC, Li FX, Li YP, et al. Antibody persistence at 18-20 months of age following primary vaccination of healthy infants with a combined DTaP-IPV//PRP-T vaccine compared to separate vaccines (DTaP, PRP-T and IPV )and immunogenicity and safety of booster vaccination in the Peoples' Republic of China[G]. 5th Asian Congress of Pediatric Infectious Diseases, 2010: 140.
  • 10Fred Zepp, Ulrich Behre, Klaus Kindler, et al. Immunogenicity and safety of a tetravalent measles-mumps-mbella-varicella vaccine co- administered with a booster dose of a combined diphtheria-tetanus- acellular pertussis-hepatitis B-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in healthy children aged 12-23 months [J ]. Eur J Pediatr, 2007, 166 (8) :857-864.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部